Back

IMUNON enters research agreement with National Cancer Institute for IMNN-001

Verifying
  • IMUNON entered a research agreement with the National Cancer Institute.
  • The agreement focuses on advancing clinical development of IMNN-001.
  • The announcement identifies the arrangement as cooperative research and development.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.
IMUNON enters research agreement with National Cancer Institute for IMNN-001 - CoinPost Terminal